Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
already received 2 doses; This non-serious case was reported by a pharmacist via other manufacturer and described the occurrence of extra dose administered in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: already received 2 doses). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 07-MAR-2025 The reporter reported that the patient came into their pharmacy for a 2nd dose of shingles and after vaccination realized they already received 2 doses, which led to extra dose administered.